Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Neuroma × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Polycystic Ovary Syndrome 8 Neoplasms 8 Infertility 5 Pain, Postoperative 3 Liver Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pulmonary Embolism 2 Neuroma, Acoustic 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leiomyoma 2 Inflammation 2 Head and Neck Neoplasms 2 Febrile Neutropenia 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Bites and Stings 2 Anovulation 2 Vomiting 1 Venous Thrombosis 1 Venous Thromboembolism 1 Unipolar Major Depression 1 Surgical Wound Infection 1 Stomatitis 1 Stomach Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡